Patients with undetectable parasitemia showed markedly lower PTX3 concentrations after therapy compared with patients who remained qPCR-positive (median PTX3: 1.545 ng/mL vs. 17.70 ng/mL; p = 0.01) (Supplementary Figure S1). The gene discussed is PTX3; the disease is parasitic infectious disease.